Dictum Health Makes Headway in Remote Patient Monitoring

Dictum Health, Inc., a top innovator in telehealth solutions for acute, post-acute, and remote patient monitoring, announced Wednesday that the company received FDA 510k clearance for spirometry, completing the cardiopulmonary capability of the IDM100 Medical Tablet.

“The system provides the most medically comprehensive telehealth solution in the market for clinical care anytime, anywhere,” a provided media release explains.

Intended for use with pediatrics and adults under supervision of a healthcare professional, the fully integrated diagnostic spirometer provides interpretation for immediate diagnostic assessment. The IDM100 Medical Tablet delivers the same clinical accuracy as an in-hospital exam, improving patient outcomes and reducing the risk of readmissions.

“Using the IDM100 Medical Tablet with the spirometry capability enables me to diagnose and assess pediatric patients’ pulmonary conditions, whether in my office or from a remote location,” said Dr. Alan Greene, pediatrician and founder of DrGreene.com.

We’re told that clinicians can connect to a specialist for further assessment, or remotely monitor their most at-risk patients who are being treated for diseases such as asthma, COPD, heart failure, hypertension, and children with asthma.

To learn more, check out Dictum Health here.

This post was written by:

- who has written 2292 posts on mHealthWatch.

Contact the author